antiparkinsonian compound (Numerate/UCB)

N/A

Report date: 2025/03/14 20:00:48
NME

Base Information

Drug Nameantiparkinsonian compound (Numerate/UCB)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNumerate Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNumerate IncUcb Sa
Active IndicationsN/A
Inactive IndicationsParkinson Disease

Other Information

ATC CodeN/A
Related LinksN/A